Redcare Pharmacy N.v. · XETR:RDC
Redcare Pharmacy — Q2 2024 Earnings Presentation
24 slides from Redcare Pharmacy's earnings presentation, Jul 30, 2024
Slide 1: Q2 2024 Earnings call presentation
¥ Redcare Q2 2024 Earnings call presentation. @SEVENUM! 30 JULY 2024 i+?)
Slide 2: Presenting live from our headquarters
ps Presenting live from our headquarters.
Slide 3: Today's presenters
Today’s presenters. Olaf Heinrich, Jasper Eenhorst, Chief Executive Officer. Chief Financial Officer.
Slide 4: Today's agenda
Today’s agenda. Ci) Financial performance. C2) Strategy update 2024. 3) Outlook and guidance. I]
Slide 5: Financial performance
Financial performance.
Slide 6: H1 2024 financial highlights
@ FINANCIAL PERFORMANCE Hi 2024 financial highlights. > Continued fast growth with record sales. Total sales up 42% in Hi 2024, reaching EUR 1,121M. Excluding last year’s acquisition of MediService, growth was 21 %. > Strong Rx growth in Germany. Quarter average Rx growth already accelerated from 7%
Slide 7: Fast growth in both segments continued
Fast growth in both segments continued. Total DACH International +41.5% i EUR 214M EUR 792M Hi 2023 Hi 2024 Hi 2023 Hi 2024 Hi 2023 Hi 2024
Slide 8: Active customers +1.5M, with high NPS
@ NON-FINANCIAL KPIs Active customers +1.5M, with high NPS. Number of customers (NPs) & 6 +0.4M Wot just +0.3M Net Promoter Score for you... Hi 2024 (Hi 2028: 74) +0.3M loam 11.6M © aoa +1.5M € 59.33 Average shopping basket value June 2023 June 2024 Hi 2024 (11 2023: 58.41) Note: due to rounding, to
Slide 9: Over 17M orders in H1, 87% from returning customers
@ NON-FINANCIAL KPIs Over 17M orders in Hi, 87% from returning customers. Share of repeat orders in percentage of total 81% 82% 83% 81% 81% ai Q2 Q3 Q4 ai 2021 Number of orders in millions 75 74 20 78 83% 85% 84% 87% 87% Q2 Q@3 a4 Qi Q2 Q3 @4 Qi Q2 2022 2023 2024 Orders: sales to end-customers / pat
Slide 10: Key financials | Profit & loss
@ KEY FINANCIALS | PROFIT & LOSS ) Hi sales up € 329M to € 1.1 billion, adj. EBITDA € 27M. MediService included since mid-Q2 2023, leading to mix impact on gross profit and selling and distribution margins when comparing year over year. in millions of euros, adjusted numbers Sales Gross profit margi
Slide 11: Stable underlying gross margin vs. H1 last year
@ KEY FINANCIALS | GROSS PROFIT MARGIN ) Stable underlying gross margin vs. Hi last year. Adjusted gross profit margin Adjusted gross profit margin in percentage of sales in percentage of sales 28.1% 28.0% 26.5% 23.4% 23.4% 23.4% Qi 2024 Q2 2024 Hi 2023 Hi 2024 Hi 2023 Hi 2024 excluding excluding Me
Slide 12: Scale and efficiencies in the cost performance
@ KEY FINANCIALS | SELLING, DISTRIBUTION AND ADMIN RATIO ) Scale and efficiencies in the cost performance. Adjusted SD&A costs Adjusted SD&A costs in percentage of sales in percentage of sales (25.5%) (21.3%) (25.3%) a (20.7%) (23.7%) (21.0%) Qi 2024 Q2 2024 Hi 2023 Hi 2024 Hi 2023 Hi 2024 excluding
Slide 13: Unabated fast organic growth with margins under control
Unabated fast organic growth with margins under control. @ Continuous double-digit growth of non-Rx @ Rx Germany taking off % Qi 2022 Q22022° @32022 @42022 Qi 2023 Q2 2023 Q3 2023 §=Q4 2023 Qi 2024 Q2 2024 7 2,5 15 0,5 EE ee Adj. EBITDA margin
Slide 14: Key financials: Cash flow
@ KEY FINANCIALS: CASH FLOW Solid cash balances. Cash flow in millions of euros 25 204 31 Dec 2023 Cash and Operating result short-term adjusted for financial assets depreciation, taxes and provisions 14 30 Working capital* movements (17) Investments* (id) Financing and foreign exchange 231 30 Jun 2
Slide 15: Strategy update 2024
strategy update 2024.
Slide 16: Update on e-Rx and CardLink
@ UPDATE ON E-RX AND CARDLINK This is just the beginning of anew digital era. > Successfully launched: CardLink solution active for patients within the Shop Apotheke app since early May. > Technologically advanced: stable, fast and easy customer journey to redeem e-scripts. > Highly accepted: positi
Slide 17: How to redeem e-Rx in Germany
(@ How To REDEEM E-RX IN GERMANY ) Today‘s redemption options. eGK plug-in. Gesundheitskarte = * 4 —_ GL, eGK without PIN 17 Paper print-out. gematik app. Insurance apps. SINCE 4 mh AOK BARMER E-Rezept? Shop Apotheke. OTHER PAYORS On patients’ request Digital ID or eGK plus PIN Digital ID or eGK plu
Slide 18: Open the Shop Apotheke app and click on e-prescription
18 Open the Shop Apotheke app and click on e-prescription on the menu. as paying by card. Simply hold the health insurance All prescriptions can be seen at a glance, card to the smartphone; the add them to the shopping cart with one e-prescriptions will be retrieved. click and complete the order.
Slide 19: Redcare's CardLink solution
@ _REDCARE’S CARDLINK SOLUTION It’s all about customer centricity. 19 One-time registration low-threshold access for returning customers. Prescriptions can be ordered 24/7 from anywhere. Real-time visibility of all prescribed medications and their availability. Preferred medicine choice can be made
Slide 20: Redcare's Rx developments so far and future potential
Redcare’s Rx developments so far and future potential. Total Rx market Germany 2024 @ Market share Redcare Pharmacy 0.45% Market share gain in Hi 2024. From 0.27% in January to 0.45% in June. t 55 b n Annualised revenue potential. +0.1pp => EUR 50 million +lpp => EUR 500 million Total addressable Rx
Slide 21: Outlook and guidance
Outlook and guidance.
Slide 22: Financial outlook and guidance 2024
@ FINANCIAL OUTLOOK AND GUIDANCE 2024 _) Guidance for full-year 2024. > Total sales to increase to EUR 2.3-2.5 billion, a growth of 30-40%. Non-Rx sales growth 15-25%. MediService to grow by mid-single digits. Adj. EBITDA margin 2% to 4%. vvevVvwyv Rx too dynamic to give guidance. Mid- to longer-ter
Slide 23: Questions
¥ Redcare questions. ask
Slide 24: @SEVENUM! JULY 2024 __—i+d)
@SEVENUM! 30 JULY 2024 __—i+d)